Medications 360 Study
Using Service Ecosystem Design Science to Co-Create and Implement the RAPID Alliance Medications 360 Strategic Framework 2022 - 2031
A $528 Billion Dollar Opportunity
A RAPID Alliance / STAR Study Initiative in the National Science Foundation Center for Health Organization Transformation at the University of Louisville in collaboration with the Frazier Polypharmacy Program at the University of Louisville, an NSF CHOT industry partner, and many other partners.
Benefits of Participating
Be part of a nationwide effort to reduce illness and mortality for millions of people, save up to $528 billion per year for the US as a whole, and generate billions of dollars of net new resources for research and action as we work, collaboratively, to optimize use of medications, vaccines and related therapies for US populations. Along the way, you will learn the new science of service ecosystem design and gain opportunities to generate new resources for yourself, your career, your organization, your friends and the world.
Be part of making meaningful change in society to reduce avoidable illness, suffering and death caused by non-optimized use of medications and vaccines, done in a way that honors and respects all people for who they are.
Risk-Bearing Purchasers, Plans and Providers
Help save millions of lives and as much as $528 billion in excess spending in US networks
Help generate hundreds of millions of dollars of net new funding to support research, education, and service
Membership Associations and Other Collaboratives
Help generate tens of millions of dollars in net new funding associations can use to advance their missions and serve members
Government Agencies (Federal, State and Local)
Gain new pathways for improving the health and wellbeing of US populations
Foundations and Philanthropy
Gain new ways to advance your mission, protect and improve health and wellbeing
Help generate hundreds of millions of dollars in net new funding to support co-creation and implementation of the strategic framework
Reduce risks and increase market share for transformational health sector investments
Digital Technology Platforms
Help co-create digital interoperability platforms and a multi-billion dollar "VISA-Like" platform for sharing person-centered, personally owned digital data at national and global scales, starting with medications and pharmacy data (invitation only)
Please join our nationwide network of universities, associations, organizations, government agencies, technology firms and others, working, collaboratively, to improve the nation's health
Together we will co-create the
RAPID Alliance Medications 360 Strategic Framework 2022 - 2031
Fund it through the
RAPID Alliance Funding Partner Network™
Implement it through the
RAPID Alliance Transformation Center Network™ (A network of participating research universities, associations, and others across the US)
And support continual improvement for everyone through the
RAPID Alliance Shared Resource Network™ (Shared resources co-created for the public good)
Upcoming Meetings and Events
All-Hands-on-Deck Strategic Plan Co-Creation Meeting #1: Welcome, Getting Organized
October 28, 2021, 1:00 – 2:30 pm. Register
All-Hands-on-Deck Co-Creation Meeting # 2: Study Section and Breakout Group Assignments
December 1, 2021, 1:00 – 2:30 pm. Register
All-Hands-on-Deck Co-Creation Meeting #3
All-Hands-on-Deck Co-Creation Meeting #4
All-Hands-on-Deck Co-Creation Meeting # 5
National Summit (Virtual)
April 11-15, 2022 (tentative)
Who Is Involved?
University Research Partners A growing network of leading US research universities, academic medical centers and schools of pharmacy includingAmerican University of Health Sciences | Belmont University | Binghamton University | California Northstate University | Chapman University | Ferris State University | Howard University | Lipscomb University | Loma Linda University | Long Island University | Marshall University | Medical College Wisconsin | Mercer University | North Dakota State | Oregon Health & Science University | Oregon State University | South Dakota State University | Sullivan University | Temple University | University of Arkansas | University of Cincinnati | University of Colorado | University of Georgia | University of Hawaii Hilo | University of Houston | University of Kentucky | University of Louisville | University of Michigan | University of Mississippi | University of Nebraska | University of Nevada Reno | University of Pittsburgh | University of Rhode Island | University of South Carolina | University of Tennessee | Washington State University, Wayne State University, Western University.
RAPID Alliance Practice Council Members A growing network of US organizations, associations, government leaders, foundations, and others interested in optimizing medications and vaccines for US populations includingPatient Advocate Foundation (PAF) | American Pharmacists Association (APhA) | American Society of Health-System Pharmacists (ASHP) | Academy of Managed Care Pharmacy (AMCP) | American Society of Consultant Pharmacists (ASCP) | American Association of Colleges of Pharmacy (AACP) | National Alliance of State Pharmacy Associations (NASPA) | National Association of Chain Drug Stores (NACDS) | National Community Pharmacies Association (NCPA) | The Community Pharmacy Foundation | CPESN USA | Sanofi and Sanofi Pasteur
RAPID Alliance Funding PartnersCommunity Pharmacy Foundation | Sanofi and Sanofi Pasteur Frazier Polypharmacy Program at the University of Louisville | National Science Foundation Center for Health Organization Transformation
RAPID Alliance Councils RAPID Alliance Practice Council Individual Members | RAPID Alliance Research Council Individual Members
RAPID Alliance Workgroups
RAPID Alliance Medications 360 Steering Workgroup Member
Who is Invited?
All key stakeholders in the US Medications and vaccine ecosystem, including universities, corporations, organizations, associations, foundations, government agencies, technology firms and others are invited to participate.
How to Get Involved
CEOs, Senior Leaders and Directors of National and State Organizations, Associations, Foundations, Government Agencies and Others
If you are a CEO, senior leader, or agency director leading an organization, association, foundation, government agency or other group with a strategic interest in improving delivery of medications and vaccines to US populations, at national or state levels, you are invited to join as a Strategic Action Partner. As a strategic action partner, you will be able to designate key leaders, experts, innovators and early stage career people in your organization to participate in the study. Benefits include a seat at the table in helping develop a national research and action agenda to address this challenge, early identification of new strategic opportunities for action in your areas of specialty, and career development opportunities for your team members.
Join as a Strategic Action Partner
University Leaders, Deans, Chairs and Researchers
If you are a university-based research leader, dean, chair or researcher with an interest in conducting research to: a.) improve delivery of medications and vaccines to US populations and/or b.) advance generalizable knowledge about how to develop and spread transformational innovations for improving health in society, you are invited to join as a University Research Partner. International researchers with an interest in sharing knowledge across national contexts are also welcome to join. Benefits of joining include a seat at the table in helping develop a national research and action agenda, new opportunities for funded research in your areas of specialty, and learning and growth opportunities for faculty and students.
Join as a University Research Partner
If you are a leader from a foundation, philanthropic organization, government agency, individual, or other entity that is interested in funding research and action to help protect and improve health and wellbeing of US populations you are invited to join as a Funding Partner. Your contributions will help support this important work.
Join as a Funding Partner
Individual Leaders, Experts, Scholars and Innovators Who Are Passionate About Optimizing Medication and Vaccine Use for US Populations
If you are a leader, expert, scholar, innovator or student operating at a local, state, national or international level who is passionate about optimizing medication and vaccine use for US populations, you are invited to join as an Individual Participant. Individual participants will have a seat at the table in co-creating and implementing a new strategic research and action agenda, and gain many opportunities to learn, connect, support, innovate and co-create.
Join as an Individual Participant
Problem: Non-optimized medication and vaccine use is one of the most significant public health challenges in the US today. Each year, this situation causes likely-avoidable illness and death for millions of people and costs as much as $528 billion annually in excess healthcare spending. Recent research has identified a strategic opportunity to address this challenge in a fundamentally new way - using service ecosystem design science.
Solution: The Service Ecosystem-Level Digitally Enabled Collaborative (SELDEC), Type 1 design is being used to align incentives for all actors in the medications ecosystem (see details here). The process begins with an all-hands-on-deck national planning process to co-create the RAPID Alliance Medications 360 Strategic Framework 2022 - 2031. The plan will then be implemented through a nationwide network of research universities, associations, consulting firms and others, working in collaboration with all key stakeholders, including government.
Action: This is a strategic opportunity to shape the medications and vaccine space in the US and beyond, in the next decade. All key stakeholders in the US medications ecosystem are encouraged to join.
Why is this Important?
The COVID-19 pandemic has highlighted an urgent need to better understand how transformational health innovations (e.g. tests, vaccines, medications and services for large populations of people) can be more rapidly developed, distributed and delivered to protect and strengthen population health. Non-optimized medication use (e.g. adverse drug events and other challenges) is associated with millions of likely-avoidable illnesses and deaths annually while costing an estimated $528 billion per year for likely-avoidable hospitalizations, emergencies and physician visits. The medications and vaccines challenge is an example of a new class of ecosystem-level health challenges which requires new kinds of research and action to address.
What we've been doing isn't working | COVID-19 pandemic | Collaboration tools and methods
The health profession sector has attempted to address the problem, but with little success for the past 30 years. The RAPID Alliance 2021 Report identified a probable reason: the need to co-create solutions using a whole ecosystem all-stakeholder approach. This is now feasible using available collaboration tools and methods, supported by service-dominant logic and service ecosystem design science approaches.
Also, as the saying goes, you should never waste a good crisis. The COVID-19 pandemic has increased many peoples' awareness of the value pharmacists and pharmacies provide in healthcare. The need to do more to encourage people to optimize their medication and vaccine use has never been stronger.
What makes this study unique is the use of service ecosystem design science to design an approach for addressing the US medications challenge at an ecosystem-level in a way that can create tangible benefits for all key stakeholders.
How Will It Work?
This project will have two phases. Phase 1 is to co-create an all-stakeholder, evidence-based, ecosystem-level strategic framework and plan and prioritized national research agenda 2022 - 2031. The Phase 2 goal, beginning in April 2022 (tentative date), is to implement the plan.
Multiple Ways to Engage
There are multiple ways to engage. You can join as an observer, participant, or in more active roles. The research platform may also be extended to help address other system challenges to health - including, for instance, coordinating research and action to address climate change risks, health equity related risks, or digital misinformation related risks. Finally, we also invite you to join us in co-creating a new Society and Journal of Health Ecosystem Research and Innovation (SHERI and JHERI) to support this work.
Benefits for Participants
Learn | Access | Contribute | Connect | Innovate | Study
Learn more about the New Science of Service-Dominant Logic and Service Ecosystem Design Science and its implications for helping you and your teams, organizations and communities improve care for those you serve.
Gain access to current best practices and emerging innovations for delivering person-centered care in today's rapidly changing environment
Know that you played a part in co-creating an ecosystem-level strategic plan and national research agenda for optimizing medication and vaccine use for the US population for the next decade
Strengthen connections with other leaders, experts and scholars
Identify new strategic opportunities for you, your teams and organizations
Researchers: New opportunities to advance research interests.
Deliverables (Phase 1)
US Medications Ecosystem Strategic Framework (2022 - 2031)
The RAPID Alliance Medications 360 study, and its "parent" study, the RAPID Alliance / STAR Study were developed based on findings from the RAPID Alliance Study conducted in 2020 during the COVID-19 pandemic. The RAPID Alliance Study identified four transformational strategies that, combined, offer potential to drive transformational improvements in medications use for US populations. The Medications 360 study supports the fourth strategy: "develop a national "big tent" research consortium. The RAPID Alliance / STAR Study provides a broad research contexts for this and other studies.
The study design was developed with input from nationally recognized leaders and scholars serving on the RAPID Alliance Practice Council and Research Council (view here), as well as leaders and scholars in the National Science Foundation Center for Health Organization Transformation.
Four Transformational Strategies
Report Infographic(the 2021 report at a glance)
Judah Thornewill, PhD
Principal InvestigatorAssistant Professor and Executive in Residence, University of Louisville, School of Public Health and Information Sciences, Department of Health Management and Systems Science. Investigator with NSF CHOT at UofL.
Demetra Antimisiaris, PharmD, BCGP, FASCP
Co-InvestigatorAssociate Professor, Director, University of Louisville Frazier Polypharmacy and Medication Management Program, School of Public Health and Information Sciences, Department of Health Management and Systems Sciences, Investigator, NSF CHOT at UofL.
Robert Esterhay, MD
Co-InvestigatorAssociate Professor and Chair Emeritus, University of Louisville, School of Public Health and Information Sciences, Department of Health Management and Systems Sciences. Investigator, NSF CHOT at UofL. Health and population health informatics.
Emmanuel Ezekekwu, PhD(c)
Graduate Research Assistant (GRA)PhD Candidate at the University of Louisville, School of Public Health and Information Sciences, Department of Health Management and Systems; Research Assistant at NSF CHOT at UofL
Tom Walton, MDiv, MS
Co-InvestigatorExecutive in Residence, University of Louisville, School of Public Health and Information Sciences, Department of Health Management and Systems Science. Modeling.
William Yasnoff, MD, PhD, FACMI
Co-InvestigatorAdjunct Professor, Health Sciences Informatics, Johns Hopkins University; Managing Partner, National Health Information Infrastructure (NHII) Advisors; Former Senior Advisor, NHII, U.S. Dept. of Health and Human Services; Former Member, Board on Population Health and Public Health Practice, National Academy of Medicine.